Rafferty Asset Management’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$712K Buy
231,271
+35,505
+18% +$151K ﹤0.01% 843
2025
Q4
$707K Buy
195,766
+39,572
+25% +$173K ﹤0.01% 852
2025
Q3
$589K Buy
156,194
+54,183
+53% +$209K ﹤0.01% 878
2025
Q2
$395K Sell
102,011
-41,661
-29% -$225K ﹤0.01% 925
2025
Q1
$718K Sell
143,672
-14,078
-9% -$89.2K ﹤0.01% 805
2024
Q4
$1.14M Buy
157,750
+1,964
+1% +$15K ﹤0.01% 768
2024
Q3
$957K Sell
155,786
-65,805
-30% -$446K ﹤0.01% 809
2024
Q2
$1.47M Sell
221,591
-661,037
-75% -$4.88M 0.01% 725
2024
Q1
$8.99M Buy
+882,628
New +$8.98M 0.03% 301
2023
Q2
Sell
-516,563
Closed -$2.18M 1092
2023
Q1
$2.18M Sell
516,563
-82,324
-14% -$978K 0.01% 590
2022
Q4
$9.85M Buy
598,887
+298,556
+99% +$3.35M 0.08% 180
2022
Q3
$3.83M Buy
+300,331
New +$4.43M 0.04% 380
2022
Q1
Sell
-362,943
Closed -$3.33M 1221
2021
Q4
$3.33M Buy
362,943
+198,865
+121% +$2.11M 0.02% 514
2021
Q3
$1.86M Sell
164,078
-17,444
-10% -$212K 0.01% 657
2021
Q2
$1.79M Sell
181,522
-17,276
-9% -$236K 0.01% 717
2021
Q1
$2.81M Buy
+198,798
New +$3.21M 0.02% 529

Other funds holding ALT

Rafferty Asset Management's ALT Position: Q1 2026 in Review

Rafferty Asset Management increased its Altimmune (ALT) stake by 18% in Q1 2026, buying an estimated $151K and bringing the position to 231,271 shares worth $712K. The position accounts for ﹤0.01% of the portfolio, ranked #843.

Rafferty Asset Management first reported a position in ALT in Q1 2021 and has held it in 16 quarters since. The position peaked at $9.85M in Q4 2022. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Rafferty Asset Management held 231,271 shares of Altimmune worth $712K as of Q1 2026.
  • Rafferty Asset Management bought 35,505 Altimmune shares in Q1 2026, an estimated $151K.
  • Altimmune made up ﹤0.01% of Rafferty Asset Management's portfolio in Q1 2026, its #843 holding.
  • Rafferty Asset Management first reported a position in Altimmune in Q1 2021 and has held it in 16 quarters since.
  • Rafferty Asset Management's Altimmune position peaked at $9.85M in Q4 2022.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.